Vital Signsby BridgeheadAll voices

01  Voice · Sector leader · Dementia

James Condulis: no photograph is held, so the sector leader plate is shown instead.
Sector leader

James Condulis

Stifel analyst

Press coverage by month · bar height shows relative volume
Oct 2026Nov 2026to date
1

Quoted in the press, across 1 topic since 14 Oct 2026

02  Quoted on · 1 of 29 topics

Open the topic

James Condulis: key facts

Kind of voice
Sector leader
Role
Stifel analyst
Quoted on
Dementia
Press coverage
Quoted in the press
Most recently quoted
14 Oct 2026

04  On the record · press

What James Condulis has said

By outlet · bar length shows relative volume
  • biopharmadive.com

Where James Condulis has been quoted

  1. Experimental Arrowhead RNAi drug hints at Alzheimer’s benefitbiopharmadive.com · 14 Oct 2026

How we found the articles that name James Condulis: we searched news for these terms.

  • dementia
  • dementia care
  • Alzheimer's
  • memory clinic
  • dementia diagnosis
  • dementia strategy

Also searched with “dementia” in each of 8 national papers, and in the Guardian by editor tag, and in trade press by category. Every term for Dementia

Verbatim

“The results "look compelling and, with subcutaneous delivery, arguably look [better] than what we've seen" with other drugs designed to cross the blood-brain barrier”
Stifel analyst · Dementia · biopharmadive.com · 14 Oct 2026 · Read the article

Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 10 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.